AdvaMedDx VALID Act Webinar

AdvaMedDx hosted an all-member educational session on the diagnostics regulatory reform bill, The VALID Act of 2021.

This report outlines a key data-driven summary of the U.S. COVID testing supply.

Read the full text of the VALID Act of 2021 as submitted to the 117th Congress.

Read a section-by-section breakdown of the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021.

AdvaMedDx wrote to affirm our commitment to make modernization of the regulatory framework for IVCTs a reality.

Modernizing regulation of diagnostic tests is essential to improve patient care and support innovation.

AdvaMedDx has prepared a high-level FAQ document that addresses key questions you may receive about the bill.

AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon re-introduction today in the House and Senate of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act for regulatory oversight of in vitro clinical tests (IVCTs).